This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dubey, P. Articles by Witte, O. N. Search for Related Content PubMed PubMed Citation Articles by Dubey, P. Articles by Witte, O. N.

Alternative Pathways to Prostate Carcinoma Activate Prostate Stem Cell Antigen Expression¹

Departments of Microbiology, Immunology and Molecular Genetics [P. D., O. N. W.], Molecular and Medical Pharmacology [H. W.]; and Urology [R. E. R.], Howard Hughes Medical Institute [O. N. W.], Los Angeles, California 90095-1662

Prostate Stem Cell Antigen (PSCA) is a glycosylphosphatidylinositol-anchored cell surface protein that is expressed in normal human prostate and overexpressed in human prostate cancers. To test whether different pathways that generate prostate cancer would affect PSCA expression, a murine model system was developed. Monoclonal antibodies were generated against murine PSCA (mPSCA). mPSCA is expressed on 20% of cells in normal prostate epithelium, and this number decreases with increasing age. In the transgenic adenocarcinoma of the mouse prostate (TRAMP) model of prostate cancer, tumors develop between 19 and 25 weeks of age. Murine PSCA was strongly expressed on 60% of the cells of TRAMP tumors, at an age where the number of PSCA+ cells and the level of expression of PSCA is very low in the normal prostate. Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) +/- mice develop a number of different cancers, including prostate cancer. The incidence of prostate cancer is low and occurs after a relatively long latency. Fluorescence-activated cell sorter analysis of prostatic tissue from 11–18-month-old PTEN +/- mice showed elevated numbers of PSCA+ cells in the prostate, and immunohistochemical analysis showed high mPSCA expression in the tumors of these mice. Together, these results show that two distinct mechanisms of carcinogenesis lead to expression of a common target antigen.

This article has been cited by other articles:

				S. Wang, A. J. Garcia, M. Wu, D. A. Lawson, O. N. Witte, and H. Wu Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation PNAS, January 31, 2006; 103(5): 1480 - 1485. [Abstract] [Full Text] [PDF]

				Z. Zhigang and S. Wenlv Prostate Stem Cell Antigen (PSCA) Expression in Human Prostate Cancer Tissues: Implications for Prostate Carcinogenesis and Progression of Prostate Cancer Jpn. J. Clin. Oncol., July 1, 2004; 34(7): 414 - 419. [Abstract] [Full Text] [PDF]

				P. K. Majumder, J. J. Yeh, D. J. George, P. G. Febbo, J. Kum, Q. Xue, R. Bikoff, H. Ma, P. W. Kantoff, T. R. Golub, et al. Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: The MPAKT model PNAS, June 24, 2003; 100(13): 7841 - 7846. [Abstract] [Full Text] [PDF]

				C. P. Tran, C. Lin, J. Yamashiro, and R. E. Reiter Prostate Stem Cell Antigen Is a Marker of Late Intermediate Prostate Epithelial Cells Mol. Cancer Res., December 1, 2002; 1(2): 113 - 121. [Abstract] [Full Text] [PDF]

				H. Ide, D. B. Seligson, S. Memarzadeh, L. Xin, S. Horvath, P. Dubey, M. B. Flick, B. M. Kacinski, A. Palotie, and O. N. Witte Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression PNAS, October 29, 2002; 99(22): 14404 - 14409. [Abstract] [Full Text] [PDF]

				A. Jain, A. Lam, I. Vivanco, M. F. Carey, and R. E. Reiter Identification of an Androgen-Dependent Enhancer within the Prostate Stem Cell Antigen Gene Mol. Endocrinol., October 1, 2002; 16(10): 2323 - 2337. [Abstract] [Full Text] [PDF]

				N. Tsuchiya, Y. Kondo, A. Takahashi, H. Pawar, J. Qian, K. Sato, M. M. Lieber, and R. B. Jenkins Mapping and Gene Expression Profile of the Minimally Overrepresented 8q24 Region in Prostate Cancer Am. J. Pathol., May 1, 2002; 160(5): 1799 - 1806. [Abstract] [Full Text] [PDF]

				T. Watabe, M. Lin, H. Ide, A. A. Donjacour, G. R. Cunha, O. N. Witte, and R. E. Reiter Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter PNAS, January 8, 2002; 99(1): 401 - 406. [Abstract] [Full Text] [PDF]